News & Updates
Filter by Specialty:
Lower rates of digestive cancer treatment in older patients due to pandemic lockdowns
The coronavirus disease 2019 (COVID-19) pandemic has led to a sharp decline in treatment for older patients with newly diagnosed cancers of the digestive system, a recent study has found.
Lower rates of digestive cancer treatment in older patients due to pandemic lockdowns
10 Jan 2022
Disease-modifying agents for multiple sclerosis do not elevate cancer risk
Several disease-modifying therapies (DMTs) for multiple sclerosis (MS) do not pose an increased risk of cancer, a study has shown.
Disease-modifying agents for multiple sclerosis do not elevate cancer risk
09 Jan 2022
Opioid use lowers LOS, deaths in nonmetastatic CRC patients
Use of opioids in the long term leads to shorter length of stay (LOS) and reduced inpatient mortality among patients hospitalized with nonmetastatic colorectal cancer (CRC), results of a study have shown. However, patients with cancer-related complications endure longer LOS and higher mortality than those admitted without such morbidities.
Opioid use lowers LOS, deaths in nonmetastatic CRC patients
09 Jan 2022
Shorter time from rectal cancer diagnosis to NCRT tied to pathologic complete response
The time elapsed between diagnosis of rectal cancer and initiation of neoadjuvant chemoradiation (NCRT) shows a significant association with pathologic complete response (pCR), and shortening this time may improve the likelihood of achieving pCR, suggests a recent study.
Shorter time from rectal cancer diagnosis to NCRT tied to pathologic complete response
08 Jan 2022
Prior stroke may influence ischaemic stroke risk in cancer patients
Prior history of ischaemic stroke appears to affect the risk of ischaemic stroke in patients newly diagnosed with cancer, according to a study from Canada presented at ASH 2021.
